{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T21:52:57Z","timestamp":1787953977995,"version":"build-2784847793"},"reference-count":61,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,26]],"date-time":"2023-10-26T00:00:00Z","timestamp":1698278400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Heart Failure"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.jchf.2023.10.004","type":"journal-article","created":{"date-parts":[[2023,11,29]],"date-time":"2023-11-29T16:40:17Z","timestamp":1701276017000},"page":"199-215","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":50,"title":["Exercise Capacity in Patients With\u00a0Obstructive Hypertrophic\u00a0Cardiomyopathy"],"prefix":"10.1016","volume":"12","author":[{"given":"Caroline J.","family":"Coats","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin S.","family":"Maron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theodore P.","family":"Abraham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iacopo","family":"Olivotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew M.Y.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Arad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuno","family":"Cardim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang-Sheng","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lubna","family":"Choudhury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans-Dirk","family":"D\u00fcngen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5470-2257","authenticated-orcid":false,"given":"Pablo","family":"Garcia-Pavia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert A.","family":"Hag\u00e8ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory D.","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Michels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3318-3643","authenticated-orcid":false,"given":"Artur","family":"Oreziak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anjali T.","family":"Owens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob","family":"Tfelt-Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josef","family":"Veselka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugh C.","family":"Watkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen B.","family":"Heitner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel L.","family":"Jacoby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart","family":"Kupfer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fady I.","family":"Malik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Wohltman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad","family":"Masri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"17","key":"10.1016\/j.jchf.2023.10.004_bib1","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1161\/01.CIR.0000066323.15244.54","article-title":"Hypertrophic cardiomyopathy: distribution of disease genes, spectrum of mutations, and implications for a molecular diagnosis strategy","volume":"107","author":"Richard","year":"2003","journal-title":"Circulation"},{"issue":"10","key":"10.1016\/j.jchf.2023.10.004_bib2","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1161\/CIRCRESAHA.121.318346","article-title":"Molecular genetic basis of hypertrophic cardiomyopathy","volume":"128","author":"Marian","year":"2021","journal-title":"Circ Res"},{"issue":"20","key":"10.1016\/j.jchf.2023.10.004_bib3","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1056\/NEJM198911163212005","article-title":"Mapping a gene for familial hypertrophic cardiomyopathy to chromosome 14q1","volume":"321","author":"Jarcho","year":"1989","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.jchf.2023.10.004_bib4","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s12551-017-0274-6","article-title":"Hypertrophic cardiomyopathy and the myosin mesa: viewing an old disease in a new light","volume":"10","author":"Trivedi","year":"2018","journal-title":"Biophys Rev"},{"issue":"25","key":"10.1016\/j.jchf.2023.10.004_bib5","doi-asserted-by":"crossref","first-page":"e159","DOI":"10.1016\/j.jacc.2020.08.045","article-title":"2020 AHA\/ACC guideline for the diagnosis and treatment of patients with hypertrophic cardiomyopathy: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"76","author":"Ommen","year":"2020","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.jchf.2023.10.004_bib6","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1001\/jamacardio.2019.4534","article-title":"Mortality among referral patients with hypertrophic cardiomyopathy vs the general European population","volume":"5","author":"Lorenzini","year":"2020","journal-title":"JAMA Cardiol"},{"issue":"9","key":"10.1016\/j.jchf.2023.10.004_bib7","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.121.009292","article-title":"Demographic and regional trends of hypertrophic cardiomyopathy-related mortality in the United States, 1999 to 2019","volume":"15","author":"Minhas","year":"2022","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jchf.2023.10.004_bib8","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.ijcard.2020.07.036","article-title":"Prevalence, causes and predictors of cardiovascular hospitalization in patients with hypertrophic cardiomyopathy","volume":"318","author":"Ciabatti","year":"2020","journal-title":"Int J Cardiol"},{"issue":"12","key":"10.1016\/j.jchf.2023.10.004_bib9","first-page":"889","article-title":"Functional and symptomatic clinical trial endpoints: the HFC-ARC Scientific Expert Panel","volume":"10","author":"Psotka","year":"2022","journal-title":"J\u00a0Am Coll Cardiol HF"},{"issue":"3","key":"10.1016\/j.jchf.2023.10.004_bib10","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.jacc.2009.01.079","article-title":"Outcome of mildly symptomatic or asymptomatic obstructive hypertrophic cardiomyopathy: a long-term follow-up study","volume":"54","author":"Sorajja","year":"2009","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"4","key":"10.1016\/j.jchf.2023.10.004_bib11","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1056\/NEJMoa021332","article-title":"Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic cardiomyopathy","volume":"348","author":"Maron","year":"2003","journal-title":"N\u00a0Engl J Med"},{"issue":"6","key":"10.1016\/j.jchf.2023.10.004_bib12","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1161\/CIRCHEARTFAILURE.114.002248","article-title":"Cardiopulmonary exercise testing and prognosis in hypertrophic cardiomyopathy","volume":"8","author":"Coats","year":"2015","journal-title":"Circ Heart Fail"},{"issue":"5","key":"10.1016\/j.jchf.2023.10.004_bib13","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.ahj.2015.02.006","article-title":"Predictors of long-term outcomes in patients with hypertrophic cardiomyopathy undergoing cardiopulmonary stress testing and echocardiography","volume":"169","author":"Masri","year":"2015","journal-title":"Am Heart J"},{"key":"10.1016\/j.jchf.2023.10.004_bib14","doi-asserted-by":"crossref","unstructured":"Cui H, Schaff HV, Olson TP, et\u00a0al. Cardiopulmonary exercise test in patients with obstructive hypertrophic cardiomyopathy. J Thorac Cardiovasc Surg. Published online May 28, 2022. https:\/\/doi.org\/10.1016\/j.jtcvs.2022.05.025","DOI":"10.1016\/j.jtcvs.2022.05.025"},{"issue":"8","key":"10.1016\/j.jchf.2023.10.004_bib15","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1136\/heartjnl-2015-308453","article-title":"Cardiopulmonary exercise test and sudden cardiac death risk in hypertrophic cardiomyopathy","volume":"102","author":"Magri","year":"2016","journal-title":"Heart"},{"issue":"10","key":"10.1016\/j.jchf.2023.10.004_bib16","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1253\/circj.CJ-16-0432","article-title":"Heart failure progression in hypertrophic cardiomyopathy - possible insights from cardiopulmonary exercise testing","volume":"80","author":"Magri","year":"2016","journal-title":"Circ J"},{"issue":"10","key":"10.1016\/j.jchf.2023.10.004_bib17","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1177\/2047487319898106","article-title":"Predictors of exercise capacity following septal myectomy in patients with hypertrophic cardiomyopathy","volume":"27","author":"Smith","year":"2020","journal-title":"Eur J Prev Cardiol"},{"issue":"5","key":"10.1016\/j.jchf.2023.10.004_bib18","first-page":"408","article-title":"Cardiopulmonary responses and prognosis in hypertrophic cardiomyopathy: a potential role for comprehensive noninvasive hemodynamic assessment","volume":"3","author":"Finocchiaro","year":"2015","journal-title":"J\u00a0Am Coll Cardiol HF"},{"issue":"39","key":"10.1016\/j.jchf.2023.10.004_bib19","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1093\/eurheartj\/ehu284","article-title":"2014 ESC guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC)","volume":"35","author":"Elliott","year":"2014","journal-title":"Eur Heart J"},{"issue":"4","key":"10.1016\/j.jchf.2023.10.004_bib20","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1161\/CIRCHEARTFAILURE.112.000122","article-title":"Treatment of obstructive hypertrophic cardiomyopathy symptoms and gradient resistant to first-line therapy with beta-blockade or verapamil","volume":"6","author":"Sherrid","year":"2013","journal-title":"Circ Heart Fail"},{"issue":"37","key":"10.1016\/j.jchf.2023.10.004_bib21","doi-asserted-by":"crossref","first-page":"3503","DOI":"10.1093\/eurheartj\/ehad194","article-title":"2023 ESC Guidelines for the management of cardiomyopathies: developed by the task force on the management of cardiomyopathies of the European Society of Cardiology (ESC)","volume":"44","author":"Arbelo","year":"2023","journal-title":"Eur Heart J"},{"issue":"18","key":"10.1016\/j.jchf.2023.10.004_bib22","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1016\/j.jacc.2015.02.061","article-title":"Hypertrophic cardiomyopathy in adulthood associated with low cardiovascular mortality with contemporary management strategies","volume":"65","author":"Maron","year":"2015","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.jchf.2023.10.004_bib23","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1001\/jamacardio.2016.0252","article-title":"Hospital volume outcomes after septal myectomy and alcohol septal ablation for treatment of obstructive hypertrophic cardiomyopathy: US nationwide inpatient database, 2003-2011","volume":"1","author":"Kim","year":"2016","journal-title":"JAMA Cardiol"},{"issue":"6","key":"10.1016\/j.jchf.2023.10.004_bib24","doi-asserted-by":"crossref","first-page":"e235","DOI":"10.1016\/j.amjmed.2017.12.031","article-title":"Clinical profile of nonresponders to surgical myectomy with obstructive hypertrophic cardiomyopathy","volume":"131","author":"Wells","year":"2018","journal-title":"Am J Med"},{"issue":"19","key":"10.1016\/j.jchf.2023.10.004_bib25","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1093\/eurheartj\/ehv693","article-title":"Long-term clinical outcome after alcohol septal ablation for obstructive hypertrophic cardiomyopathy: results from the Euro-ASA registry","volume":"37","author":"Veselka","year":"2016","journal-title":"Eur Heart J"},{"issue":"5","key":"10.1016\/j.jchf.2023.10.004_bib26","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/0092-8674(90)90274-I","article-title":"A\u00a0molecular basis for familial hypertrophic cardiomyopathy: a beta cardiac myosin heavy chain gene missense mutation","volume":"62","author":"Geisterfer-Lowrance","year":"1990","journal-title":"Cell"},{"issue":"6273","key":"10.1016\/j.jchf.2023.10.004_bib27","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1126\/science.aad3456","article-title":"A\u00a0small-molecule inhibitor of sarcomere contractility suppresses hypertrophic cardiomyopathy in mice","volume":"351","author":"Green","year":"2016","journal-title":"Science"},{"issue":"Supplement 1","key":"10.1016\/j.jchf.2023.10.004_bib28","article-title":"Effect of mavacamten on systolic anterior motion of the mitral valve and mitral regurgitation in patients with obstructive hypertrophic cardiomyopathy: insights from the VALOR-HCM study","volume":"146","author":"Cremer","year":"2022","journal-title":"Circulation"},{"issue":"10253","key":"10.1016\/j.jchf.2023.10.004_bib29","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/S0140-6736(20)31792-X","article-title":"Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"396","author":"Olivotto","year":"2020","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.jchf.2023.10.004_bib30","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.jacc.2022.04.048","article-title":"Myosin inhibition in patients with obstructive hypertrophic cardiomyopathy referred for septal reduction therapy","volume":"80","author":"Desai","year":"2022","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"19","key":"10.1016\/j.jchf.2023.10.004_bib31","doi-asserted-by":"crossref","first-page":"14142","DOI":"10.1021\/acs.jmedchem.1c01290","article-title":"Discovery of aficamten (CK-274), a next-generation cardiac myosin inhibitor for the treatment of hypertrophic cardiomyopathy","volume":"64","author":"Chuang","year":"2021","journal-title":"J\u00a0Med Chem"},{"issue":"7","key":"10.1016\/j.jchf.2023.10.004_bib32","first-page":"735","article-title":"Cardiac myosin inhibitors for managing obstructive hypertrophic cardiomyopathy: JACC: Heart\u00a0Failure State-of-the-Art Review","volume":"11","author":"Ostrominski","year":"2023","journal-title":"J\u00a0Am Coll Cardiol HF"},{"issue":"8","key":"10.1016\/j.jchf.2023.10.004_bib33","first-page":"763","article-title":"A\u00a0phase 1 dose-escalation study of the cardiac myosin inhibitor aficamten in healthy participants","volume":"7","author":"Malik","year":"2022","journal-title":"J\u00a0Am Coll Cardiol Basic Trans Science"},{"issue":"25","key":"10.1016\/j.jchf.2023.10.004_bib34","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.1016\/j.jacc.2021.07.065","article-title":"Randomized trial of metoprolol in patients with obstructive hypertrophic cardiomyopathy","volume":"78","author":"Dybro","year":"2021","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"11","key":"10.1016\/j.jchf.2023.10.004_bib35","doi-asserted-by":"crossref","first-page":"741","DOI":"10.7326\/M18-3016","article-title":"Mavacamten treatment for obstructive hypertrophic cardiomyopathy: a clinical trial","volume":"170","author":"Heitner","year":"2019","journal-title":"Ann Intern Med"},{"issue":"1","key":"10.1016\/j.jchf.2023.10.004_bib36","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0735-1097(99)00173-4","article-title":"Comparison of dual-chamber pacing versus septal myectomy for the treatment of patients with hypertrophic obstructive cardiomyopathy: a comparison of objective hemodynamic and exercise end points","volume":"34","author":"Ommen","year":"1999","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"8","key":"10.1016\/j.jchf.2023.10.004_bib37","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1161\/01.CIR.95.8.2075","article-title":"Nonsurgical septal reduction for hypertrophic obstructive cardiomyopathy: outcome in the first series of patients","volume":"95","author":"Knight","year":"1997","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.jchf.2023.10.004_bib38","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1016\/S0735-1097(01)01614-X","article-title":"Comparison of ethanol septal reduction therapy with surgical myectomy for the treatment of hypertrophic obstructive cardiomyopathy","volume":"38","author":"Nagueh","year":"2001","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"20","key":"10.1016\/j.jchf.2023.10.004_bib39","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1053\/euhj.2002.3285","article-title":"Septal myotomy-myectomy and transcoronary septal alcohol ablation in hypertrophic obstructive cardiomyopathy. A comparison of clinical, haemodynamic and exercise outcomes","volume":"23","author":"Firoozi","year":"2002","journal-title":"Eur Heart J"},{"issue":"11","key":"10.1016\/j.jchf.2023.10.004_bib40","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/j.ejheart.2008.09.005","article-title":"Long term exercise capacity in patients with hypertrophic cardiomyopathy treated with percutaneous transluminal septal myocardial ablation","volume":"10","author":"Malek","year":"2008","journal-title":"Eur J Heart Fail"},{"issue":"2","key":"10.1016\/j.jchf.2023.10.004_bib41","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/0002-9149(79)90307-2","article-title":"Exercise performance after septal myotomy and myectomy in patients with obstructive hypertrophic cardiomyopathy","volume":"44","author":"Redwood","year":"1979","journal-title":"Am J Cardiol"},{"issue":"19","key":"10.1016\/j.jchf.2023.10.004_bib42","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1016\/0002-9149(92)90713-9","article-title":"Predictors of exercise benefit after operative relief of left ventricular outflow obstruction by the myotomy-myectomy procedure in hypertrophic cardiomyopathy","volume":"69","author":"Diodati","year":"1992","journal-title":"Am J Cardiol"},{"issue":"16","key":"10.1016\/j.jchf.2023.10.004_bib43","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1016\/j.jacc.2022.02.024","article-title":"Effects of metoprolol on exercise hemodynamics in patients with obstructive hypertrophic cardiomyopathy","volume":"79","author":"Dybro","year":"2022","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.jchf.2023.10.004_bib44","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1161\/01.CIR.91.2.580","article-title":"Exercise standards. A statement for healthcare professionals from the American Heart Association. Writing Group","volume":"91","author":"Fletcher","year":"1995","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.jchf.2023.10.004_bib45","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1161\/CIRCULATIONAHA.105.583500","article-title":"Prevalence, clinical profile, and significance of left ventricular remodeling in the end-stage phase of hypertrophic cardiomyopathy","volume":"114","author":"Harris","year":"2006","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.jchf.2023.10.004_bib46","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jacc.2022.10.020","article-title":"Phase 2 study of aficamten in patients with obstructive hypertrophic cardiomyopathy","volume":"81","author":"Maron","year":"2023","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"8","key":"10.1016\/j.jchf.2023.10.004_bib47","first-page":"531","article-title":"Validation of the Kansas City Cardiomyopathy Questionnaire in symptomatic obstructive hypertrophic cardiomyopathy","volume":"10","author":"Nassif","year":"2022","journal-title":"J\u00a0Am Coll Cardiol HF"},{"issue":"24","key":"10.1016\/j.jchf.2023.10.004_bib48","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1016\/j.jacc.2013.04.004","article-title":"B-type natriuretic peptide and survival in hypertrophic cardiomyopathy","volume":"61","author":"Geske","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"23","key":"10.1016\/j.jchf.2023.10.004_bib49","article-title":"Circulating biomarkers in hypertrophic cardiomyopathy","volume":"11","author":"Matthia","year":"2022","journal-title":"J\u00a0Am Heart Assoc"},{"issue":"9","key":"10.1016\/j.jchf.2023.10.004_bib50","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1016\/j.jacc.2019.06.055","article-title":"Natriuretic peptide response and outcomes in\u00a0chronic heart failure with reduced ejection fraction","volume":"74","author":"Januzzi","year":"2019","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"11","key":"10.1016\/j.jchf.2023.10.004_bib51","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1016\/j.cardfail.2023.07.003","article-title":"Aficamten for drug-refractory severe obstructive hypertrophic cardiomyopathy in patients receiving disopyramide: REDWOOD-HCM cohort 3","volume":"29","author":"Owens","year":"2023","journal-title":"J Card Fail"},{"issue":"8","key":"10.1016\/j.jchf.2023.10.004_bib52","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/S0735-1097(23)00768-4","article-title":"Long-term efficacy and safety of aficamten in patients with symptomatic obstructive hypertrophic cardiomyopathy (abstr)","volume":"81","author":"Saberi","year":"2023","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2023.10.004_bib53","unstructured":"Saberi S, Masri A, Abraham TP, et\u00a0al. Improvement in KCCQ scores in patients with obstructive hypertrophic cardiomyopathy treated with aficamten in the REDWOOD-HCM OLE study. Paper presented at: Heart\u00a0Failure Society of America (HFSA) 26th Annual Scientific Meeting; September 30 through October 3, 2022; Washington, DC."},{"issue":"2","key":"10.1016\/j.jchf.2023.10.004_bib54","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.ijcard.2010.08.026","article-title":"Chronotropic incompetence and its relation to exercise intolerance in hypertrophic cardiomyopathy","volume":"153","author":"Efthimiadis","year":"2011","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jchf.2023.10.004_bib55","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.ijcard.2018.04.019","article-title":"Clinical and prognostic impact of chronotropic incompetence in patients with hypertrophic cardiomyopathy","volume":"271","author":"Magri","year":"2018","journal-title":"Int J Cardiol"},{"issue":"7","key":"10.1016\/j.jchf.2023.10.004_bib56","first-page":"1347","article-title":"Prognostic value of reduced heart rate reserve during exercise in hypertrophic cardiomyopathy","volume":"10","author":"Ciampi","year":"2021","journal-title":"J\u00a0Clin Med"},{"issue":"10","key":"10.1016\/j.jchf.2023.10.004_bib57","doi-asserted-by":"crossref","first-page":"2886","DOI":"10.1161\/01.CIR.92.10.2886","article-title":"Exercise capacity in hypertrophic cardiomyopathy. Role of stroke volume limitation, heart rate, and diastolic filling characteristics","volume":"92","author":"Lele","year":"1995","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.jchf.2023.10.004_bib58","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1136\/heartjnl-2013-304914","article-title":"Cardiac output response and peripheral oxygen extraction during exercise among symptomatic hypertrophic cardiomyopathy patients with and without left ventricular outflow tract obstruction","volume":"100","author":"Critoph","year":"2014","journal-title":"Heart"},{"issue":"7","key":"10.1016\/j.jchf.2023.10.004_bib59","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1056\/NEJMra1710575","article-title":"Clinical course and management of hypertrophic cardiomyopathy","volume":"379","author":"Maron","year":"2018","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.jchf.2023.10.004_bib60","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1002\/ejhf.2737","article-title":"Effect of beta-blocker therapy on the response to mavacamten in patients with symptomatic obstructive hypertrophic cardiomyopathy","volume":"25","author":"Wheeler","year":"2023","journal-title":"Eur J Heart Fail"},{"issue":"10","key":"10.1016\/j.jchf.2023.10.004_bib61","article-title":"Hospital procedural volume and clinical outcomes following septal reduction therapy in obstructive hypertrophic cardiomyopathy","volume":"12","author":"Altibi","year":"2023","journal-title":"J\u00a0Am Heart Assoc"}],"container-title":["JACC: Heart Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213177923006893?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213177923006893?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,2,15]],"date-time":"2024-02-15T04:25:23Z","timestamp":1707971123000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213177923006893"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":61,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["S2213177923006893"],"URL":"https:\/\/doi.org\/10.1016\/j.jchf.2023.10.004","relation":{},"ISSN":["2213-1779"],"issn-type":[{"value":"2213-1779","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exercise Capacity in Patients With\u00a0Obstructive Hypertrophic\u00a0Cardiomyopathy","name":"articletitle","label":"Article Title"},{"value":"JACC: Heart Failure","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jchf.2023.10.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation.","name":"copyright","label":"Copyright"}]}}